Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Mammography Workstation Features Dynamic MRI Assessment and High-Speed Volume Rendering

By MedImaging International staff writers
Posted on 08 Aug 2013
A new mammography workstation provides excellent image loading times, consistent reading, and an intuitive user interface, including the evaluation of dynamic breast magnetic resonance imaging (MRI) studies.

Aycan Medical Systems’ (Rochester, NY, USA) US Food and Drug Administration (FDA)-cleared mammography workstation, powered by aycan OsiriX Pro with its advanced hanging protocol plug-in, is optimized for mammography workflow.

Suitable for mammography workstations, the optional hanging protocols plug-in for aycan OsiriX Pro allows the user to save display layouts and settings in the two-dimensional (2D) Viewer, so when reopening a study (or similar studies), the user will always obtain the same view. This standardization brings greater effectiveness to routine diagnoses. The plug-in additionally automatically opens up earlier studies, which further increases the speed of the daily workflow. With this plug-in, aycan OsiriX Pro can now be used as a mammography workstation in the field of curative treatment and screening.

Key features of the technology include: easy to use; faster workflow with aycan OsiriX Pro; easy to reconfigure; hanging protocol import/export; change layout with just one click or keyboard short cut; image parameters: pre-define zoom, window width/window level (WW/WL), image numbers, screen layout; and group and tile similar studies.

Related Links:

Aycan Medical Systems


Digital Intelligent Ferromagnetic Detector
Digital Ferromagnetic Detector
Post-Processing Imaging System
DynaCAD Prostate
Mammography System (Analog)
MAM VENUS
Multi-Use Ultrasound Table
Clinton

Channels

Nuclear Medicine

view channel
Image: This artistic representation illustrates how the drug candidate NECT-224 works in the human body (Photo courtesy of HZDR/A. Gruetzner)

Radiopharmaceutical Molecule Marker to Improve Choice of Bladder Cancer Therapies

Targeted cancer therapies only work when tumor cells express the specific molecular structures they are designed to attack. In urothelial carcinoma, a common form of bladder cancer, the cell surface protein... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.